Jae Hoon Lim

Jae Hoon Lim

Auto-generated profile, based on publicly available information

Jae Hoon Lim

Samsung Medical Center, Sungkyunkwan University School of Medicine

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2003 in American Journal of Roentgenology
Verified
Journal Article
Closed access
JLJae Hoon Lim
Jae Hoon Lim

3 October 2007 in Abdominal Radiology
Verified
Journal Article
Closed access
PDF file
BCBenedikt V. Czermak
Benedikt V. Czermak
OAOkan Akhan
Okan Akhan
RHRenate Hiemetzberger
Renate Hiemetzberger
BZBettina Zelger
Bettina Zelger
WVWolfgang Vogel
Wolfgang Vogel
JLJae Hoon Lim
Jae Hoon Lim

1 January 2004 in RadioGraphics
Verified
Journal Article
Closed access
JLJae Hoon Lim
Jae Hoon Lim
KYKwon-Ha Yoon
Kwon-Ha Yoon
SKSeong Hyun Kim
Seong Hyun Kim
HKHa Young Kim
Ha Young Kim
HLHyo Keun Lim
Hyo Keun Lim
KNKyung Jin Nam
Kyung Jin Nam
Papillary tumors of the bile ducts are intraductal tumors with numerous minute frondlike papillary projections. Some intraductal papillary tumors of the bile ducts produce a large amount of mucin that disturbs bile flow and causes severe biliary dilatation. In the presence of a tumor of this subgroup, the entire biliary tree is dilated; segmental or lobar bile ducts are dilated disproportionately, and aneurysmal dilatation may occur. Mucin is depicted at cholangiography as multiple elongated or cordlike filling defects, and the tumor is depicted on cross-sectional images as a castlike, polypoid, or fungating mass in the dilated biliary tree. Based on these characteristic imaging features—dilatation, mucin, and tumor—correct diagnosis of intraductal papillary mucinous tumor of the bile ducts may be made. © RSNA, 2004

1 March 2001 in RadioGraphics
Verified
Journal Article
Closed access
JLJae Hoon Lim
Jae Hoon Lim
GLGina Lee
Gina Lee
YOYoung Lyun Oh
Young Lyun Oh
"Intraductal papillary mucinous tumor" is now the preferred term to describe a spectrum of proliferation of the pancreatic ductal epithelium. The tumor produces an excessive amount of mucin and results in progressive dilation of the main pancreatic duct or cystic dilation of the branch ducts, depending on the location of the tumor. This tumor is small and localized in a segment of the main pancreatic duct or in branch ducts, particularly in the branch ducts of the uncinate process, but it may also be diffuse, involving a wide area of the pancreatic ducts. Excessive mucin may impede the pancreatic duct flow and, in turn, produce symptoms of chronic pancreatitis. The following findings are seen on imaging studies: lobulated multicystic dilatation of the branch ducts, diffuse dilatation of the main pancreatic duct, intraductal papillary tumors, elongated or globlike mucous plugs in the dilated ducts, and bulging of the papilla into the duodenal lumen. The diagnosis is suggested at ultrasonography, computed tomography, or magnetic resonance cholangiopancreatography. Endoscopic retrograde cholangiopancreatography is the imaging modality of choice for the diagnosis, because it depicts the communication between the cystically dilated branch ducts and the diffusely dilated main pancreatic duct, as well as intraductal papillary tumor and mucous plugs.

1 May 2000 in Radiology
Verified
Journal Article
Closed access
HJHyun-Jung Jang
Hyun-Jung Jang
JLJae Hoon Lim
Jae Hoon Lim
SLSoon Jin Lee
Soon Jin Lee
CPCheol Keun Park
Cheol Keun Park
HPHong Suk Park
Hong Suk Park
YDYoung Soo Do
Young Soo Do
To determine whether the combination of CT during arterial portography (CTAP) and CT hepatic arteriography (CTHA) provides an added benefit to triple-phase helical CT (THCT) alone in the preoperative evaluation of hepatocellular carcinoma (HCC). Fifty-two consecutive patients with pathologically proved HCC underwent THCT (hepatic arterial, portal venous, and delayed phases) and combined CTAP and CTHA. Two radiologists reviewed the images in three sessions: first the THCT images alone, then with the CTAP images, and finally all three sets of images. There were 73 pathologically confirmed HCCs. Among 72 lesions considered as HCC at THCT, 69 were proved to be HCCs. Of the additional 37 nodules interpreted as HCC at CTAP, only one was confirmed as such. Among the additional 20 lesions presumed to be HCC at combined CTAP and CTHA, only two were proved to be HCCs. The sensitivity was 94% (69 of 73 lesions) at THCT, 96% (70 of 73) with additional CTAP, and 97% (71 of 73) with all three modalities. The positive predictive value was 96% (69 of 72) at THCT, 65% (70 of 107) with additional CTAP, and 80% (71 of 89) with all three modalities. The use of CTAP and CTHA, in addition to being invasive and costly, resulted in an unacceptably high false-positive rate without a substantial increase in sensitivity. Therefore, CTAP and CTHA are not recommended for preoperative evaluation of HCC; THCT alone is preferred.

23 June 2004 in Abdominal Radiology
Verified
Journal Article
Closed access
PDF file
JLJ. H. Lim
J. H. Lim
CPC. K. Park
C. K. Park